Navigation Links
ERT to Showcase Its Clinical Trials Portfolio at DIA's 45th Annual Meeting at Booth #507
Date:6/15/2009

PHILADELPHIA, June 15 /PRNewswire/ -- ERT (Nasdaq: ERES), a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, announced today that it will be showcasing its portfolio of products and services at Booth #507 at the 45th Annual DIA Meeting, 21-25 June 2009 in San Diego, CA.

ERT will be showcasing, for the first time since its successful Company rebranding exercise, its four new sub-brands of its industry-leading products and services, including ERT ePRO Solutions, ERT Cardiac Safety Solutions, ERT EDC Solutions, and ERT Clinical Research Consulting Group. ERT representatives will be at the ERT booth at the DIA Annual Meeting to discuss the Company's latest innovations, as well as the latest advancements within the industry.

ERT is also inviting delegates to attend a presentation from its partner, Healthcare Technology Systems (HTS) Inc., which will be held on Wednesday, June 24, 3.30pm-5.00pm. The presentation entitled "Addressing Suicidality in Clinical Trials" will be chaired by John H. Greist, MD of HTS Inc and will discuss FDA safety concerns and regulatory requirements regarding suicidality assessments and the Columbia Suicide Severity Rating Scale (C-SSRS) and Columbia Classification Algorithm of Suicide Assessment (C-CASA). Delegates will be able to learn about computer-automated suicidality assessment options, as well as learn about methods and techniques for follow-up with patients. For further information or to register for this presentation, please visit www.ert.com/ePRO.

The DIA Annual Meeting is the biopharmaceutical industry's largest global event, drawing over 5,000 industry professionals each year and over 450 exhibiting companies from all over the world. Additionally, DIA Annual features over 400 conference sessions including key speakers from key regulatory agencies, e.g. FDA and EMEA.

ERT is a leading provider of technology and services to the biopharmaceutical and medical device industries around the world. The four key areas of ERT products and services are all enabled by the Company's innovative technology platform -- EXPERT(TM). EXPERT(TM) is a robust, secure, and validated clinical-research workflow-processing system that powers centralized electronic data collection, data management, and information exchange.

For further information about ERT's clinical trial solutions please visit Booth # 507 at DIA 45th Annual Meeting. Alternatively, email info@ert.com, call +1 215 972 0420 or visit www.ert.com.

For further press information, contact Fiona Robinson, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, Fax +44 1477 539540, Email ert@scottpr.co.uk

ERT

Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) (www.ert.com) is a provider of technology and services to the global biopharmaceutical and medical device industries. The Company is the market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company also provides technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2009 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE ERT
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. TechConnect World Conference Showcases Houston Leaders May 3-7, at the George R. Brown Convention Center
2. Eklin Medical Systems to Showcase RapidStudy(TM) CDx Digital Radiography Systems at CVC East
3. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
4. Siemens Showcases New Hearing Loss Solutions at AudiologyNOW! Conference
5. ERT to Showcase Its Clinical Trials Portfolio at DIAs 21st Euromeeting
6. DAZ Systems, Inc. Showcases Oracle Business Accelerator for Agile Product Lifecycle Management
7. Stereotaxis Showcases Advancements for Remote Magnetic Ablations
8. NexBio to Present at 2009 Biotech Showcase
9. VivoMetrics to Present at the 2009 Biotech Showcase
10. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
11. Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... The need for blood donations in South Texas and across the ... Texas Blood & Tissue Center, blood donations are on the decline. In fact, donations across ... down 21 percent in South Texas in the last four years alone. , There is ...
(Date:5/23/2016)... , May 23, 2016 Oxitec ... 25 th at 10:15 a.m. ET before the United ... role genetically engineered mosquitos can play in controlling the spread ... of the Zika virus.      (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ... male mosquito with a self-limiting gene. Trials in ...
(Date:5/23/2016)... ... May 23, 2016 , ... Foresight Institute , ... the winners for the 2015 Foresight Institute Feynman Prizes. , These prestigious ... categories, one for experiment and the other for theory in nanotechnology. Prof. Markus ...
(Date:5/20/2016)... Minneapolis, MN (PRWEB) , ... May 20, 2016 , ... ... and consumer goods companies, today announced its official 25th anniversary of the business. “We ... we are so grateful to our customers for the privilege and honor of serving ...
Breaking Biology Technology:
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):